全文获取类型
收费全文 | 2370篇 |
免费 | 163篇 |
国内免费 | 27篇 |
专业分类
耳鼻咽喉 | 15篇 |
儿科学 | 55篇 |
妇产科学 | 27篇 |
基础医学 | 281篇 |
口腔科学 | 85篇 |
临床医学 | 252篇 |
内科学 | 497篇 |
皮肤病学 | 25篇 |
神经病学 | 115篇 |
特种医学 | 72篇 |
外科学 | 465篇 |
综合类 | 66篇 |
一般理论 | 2篇 |
预防医学 | 164篇 |
眼科学 | 66篇 |
药学 | 217篇 |
中国医学 | 18篇 |
肿瘤学 | 138篇 |
出版年
2024年 | 7篇 |
2023年 | 44篇 |
2022年 | 123篇 |
2021年 | 151篇 |
2020年 | 102篇 |
2019年 | 107篇 |
2018年 | 113篇 |
2017年 | 78篇 |
2016年 | 83篇 |
2015年 | 100篇 |
2014年 | 94篇 |
2013年 | 103篇 |
2012年 | 169篇 |
2011年 | 198篇 |
2010年 | 90篇 |
2009年 | 73篇 |
2008年 | 131篇 |
2007年 | 157篇 |
2006年 | 125篇 |
2005年 | 114篇 |
2004年 | 86篇 |
2003年 | 81篇 |
2002年 | 68篇 |
2001年 | 13篇 |
2000年 | 15篇 |
1999年 | 18篇 |
1998年 | 7篇 |
1996年 | 9篇 |
1995年 | 5篇 |
1994年 | 7篇 |
1992年 | 2篇 |
1991年 | 8篇 |
1990年 | 12篇 |
1989年 | 10篇 |
1988年 | 3篇 |
1987年 | 6篇 |
1986年 | 4篇 |
1985年 | 7篇 |
1984年 | 3篇 |
1983年 | 4篇 |
1981年 | 3篇 |
1979年 | 4篇 |
1978年 | 2篇 |
1973年 | 2篇 |
1971年 | 4篇 |
1969年 | 3篇 |
1968年 | 1篇 |
1967年 | 2篇 |
1964年 | 1篇 |
1909年 | 1篇 |
排序方式: 共有2560条查询结果,搜索用时 0 毫秒
101.
Iida M Llena JF Suarez MA Malik S Weidenheim KM LaSala P Hirano A 《Brain tumor pathology》2002,19(1):41-45
Meningeal melanocytoma is a rare pigmented tumor originating from the melanocytes that generally occurs in the posterior fossa
and the spinal cord. Although it is known as a relatively benign tumor, some recurrences have been reported. We report two
cases of spinal meningeal melanocytoma with immunohistochemical and ultrastructural studies. In addition, we include a summary
of published cases since the first case of Limas and Tio in 1972. 相似文献
102.
Fernandes H Gregson BA Siddique MS Mendelow AD 《Stroke; a journal of cerebral circulation》2002,33(6):1455-6; author reply 1455-6
103.
Anthony J Greisinger Rajesh Balkrishnan Rahul A Shenolikar Oscar A Wehmanen Shahid Muhammad P Kay Champion 《Disease management》2004,7(4):325-332
Scant evidence exists that examines the impact of participation in primary care diabetes management programs and their educational components on the risk of subsequent significant patient morbidity. This study examined the association between participation in a diabetes management program in a primary care setting and the risk of subsequent hospitalization. Ten thousand nine hundred eighty patients with diabetes mellitus receiving some type of treatment in a large primary care clinic network in Houston, TX were examined for incidence of hospitalization in the year 2002. Information from the year preceding the hospitalization was obtained on several demographic, clinical, and diabetes care management participation related variables. Multivariate logistic regressions were used to examine the relationship between primary care diabetes management participation as well as individual educational components and the likelihood of subsequent-year hospitalization. Patients participating in some type of primary care diabetes management were 16% less likely to have an incidence of hospitalization (p = 0.05). When individual educational components of the diabetes care management program were examined, diabetes education sessions were more beneficial than certified diabetes educator visits in reducing the incidence of hospitalization. Patients with controlled blood glucose levels and a diabetes education session seemed to have the most significant reduction in hospitalization risk (odds ratio [OR] = 0.62; 95% CI: 0.40, 0.95). There seem to be beneficial effects associated with participation in primary care diabetes management programs in terms of reduced hospitalization risk. Attendance at diabetes educational sessions in primary care settings coupled with maintenance of blood glucose control seem to be associated with greatest risk reduction. 相似文献
104.
105.
106.
107.
A survey was undertaken to assess the knowledge, attitude and practice of medical ethics among surgical residents and interns in three teaching hospitals of Karachi, Pakistan. 101 out of 120 completed responses were included in the study. Fifty-one respondents had heard about the Code of Ethics formulated by the Pakistan Medical and Dental Council. Forty-four had read the code. Seven had no knowledge about it. Forty-seven reported taking consent for procedures. Forty-two respondents gave correct answers on questions of confidentiality and knowledge of law pertaining to trauma victims. Only 11 reported having been taught ethics as students. Four did not feel the need of its teaching at an undergraduate level. Doctors graduating within the last 10 years gave fewer correct answers than those graduating earlier. Knowledge of medical ethics and its application on the surgical floors is extremely poor. The survey results support the view that medical ethics should be part of the undergraduate medical curriculum. 相似文献
108.
McCurry KR Iacono A Zeevi A Yousem S Girnita A Husain S Zaldonis D Johnson B Hattler BG Starzl TE 《The Journal of thoracic and cardiovascular surgery》2005,130(2):528-537
OBJECTIVES: Acute and chronic rejection remain unresolved problems after lung transplantation, despite heavy multidrug immunosuppression. In turn, the strong immunosuppression has been responsible for mortality and pervasive morbidity. It also has been postulated to interdict potential mechanisms of alloengraftment. METHODS: In 48 lung recipients we applied 2 therapeutic principles: (1) recipient pretreatment with antilymphoid antibody preparations (Thymoglobulin [SangStat, Fremont, Calif] or Campath [alemtuzumab; manufactured by ILEX Pharmaceuticals, LP, San Antonio, Tex; distributed by Berlex Laboratories, Richmond, Calif]) and (2) minimal posttransplant immunosuppression with tacrolimus monotherapy or near-monotherapy. Our principal analysis was of the events during the critical first 6 posttransplant months of highest immunologic and infectious disease risk. Results were compared with those of 28 historical lung recipients treated with daclizumab induction and triple immunosuppression (tacrolimus-prednisone-azathioprine). RESULTS: Recipient pretreatment with both antilymphoid preparations allowed the use of postoperative tacrolimus monotherapy with prevention or control of acute rejection. Freedom from rejection was significantly greater with Campath than with Thymoglobulin (P = .03) or daclizumab (P = .05). After lymphoid depletion with Thymoglobulin or Campath, patient and graft survival at 6 months was 90% or greater. Patient and graft survival after 9 to 24 months is 84.2% in the Thymoglobulin cohort, and after 10 to 12 months, it is 90% in the Campath cohort. There has been a subjective improvement in quality of life relative to our historical experience. CONCLUSION: Our results suggest that improvements in lung transplantation can be accomplished by altering the timing, dosage, and approach to immunosuppression in ways that might allow natural mechanisms of alloengraftment and diminish the magnitude of required maintenance immunosuppression. 相似文献
109.
110.